Concepedia

Publication | Open Access

Interleukin‐34 Reprograms Glycolytic and Osteoclastic Rheumatoid Arthritis Macrophages via Syndecan 1 and Macrophage Colony‐Stimulating Factor Receptor

DOIFull Paper Access

41

Citations

37

References

2021

Year

Katrien Van Raemdonck, Sadiq Umar, Karol Palasiewicz, Michael V. Volin, Hatem A. Elshabrawy, Bianca Romay, Chandana Tetali, Azam Ahmed, M. Asif Amin, Ryan K. Zomorrodi,
Arthritis & Rheumatology

Abstract

IL-34 is a novel endogenous factor that remodels hypermetabolic M34 macrophages and facilitates their cross-regulation with T effector cells to advance inflammatory bone destruction in RA.

References

YearCitations

Page 1